Webinar for Behavioral Health Providers: Cognitive Behavioral Therapy in Epilepsy

Webinar on Thursday, February 6, 2020, 2:00 to 3:00 p.m. ET

Download the Webinar Flyer

Please join us for a webinar hosted by the National Association of County Behavioral Health and Developmental Disability Directors (NACBHDD) and the Epilepsy Foundation, titled “Cognitive Behavioral Therapy in Epilepsy.”

• Many people with epilepsy report that psychological factors in everyday life can affect how often they have seizures.
• Treatment for people impacted by epilepsy most often begins with anti-seizure medication.
• Psychological or behavioral therapies, including cognitive behavioral therapy (CBT), also can be used to assist people living with epilepsy increase their ability to cope with their chronic condition.
• Treatment goals include improved seizure control, psychological wellbeing and quality of life.

Webinar

“Cognitive Behavioral Therapy in Epilepsy”

• Date: Thursday, February 6, 2020
• Time: 2:00 - 3:00 p.m. EST

You can positively impact the lives of your patients by increasing your knowledge of CBT in the treatment of people with epilepsy. This webinar will

• Identify important CBT concepts and techniques
• Review the indications for CBT in epilepsy
• Describe outcomes in people with epilepsy treated with CBT
• Identify resources for mindfulness practices

Moderator

Ron Manderscheid PhD
Executive Director
National Association of County Behavioral Health & Developmental Disability Directors and
National Association for Rural Mental Health

Guest Speakers

W Curt LaFrance Jr, MD, MPH
Professor of Psychiatry and Neurology,
Alpert Medical School, Brown University
Director of Neuropsychiatry and Behavioral Neurology, Rhode Island Hospital

Elaine T Kiriakopoulos, MD, MSc
Director, National Health Communications and Engagement, Epilepsy Foundation
Clinical Research Associate, Department of Neurology
Comprehensive Epilepsy Center, Dartmouth Hitchcock Medical Center, New Hampshire

This program is made possible with funding from the Centers for Disease Control and Prevention (CDC) under cooperative agreement number 1U58DP0026256-04-00, CFDA 93.850. Its contents are solely the responsibility of the authors and do not necessarily represent the views of the CDC.